Direct-To-Consumer Genetic Testing Devices Can Help Reducing Mortality Rate Of Cancer Patients

Direct-To-Consumer Genetic Testing Devices
Direct-To-Consumer Genetic Testing Devices

Direct-To-Consumer Genetic Testing Devices are used to detect the risk of certain diseases, such as Huntington's disease and Fragile X Syndrome. This technology provides results faster than lab tests. It has also reduced the costs of testing. It is available in stores and can be purchased online. It allows customers to access the information they need to take appropriate measures to protect themselves from future health problems. The results of the test are usually available in three days or less.

Using Direct-To-Consumer Genetic Testing Devices Market, individuals can get a better understanding of their ancestry.

They can also find out if they have genetic disease carriers or other genetic risks. They can also make a proactive approach to their health. Previously, genetic testing required the help of a qualified clinician or healthcare provider. But, with the rise in technology and the growing number of consumers, direct-to-consumer genetic testing is offered by many companies. This technology has helped in reducing the mortality rates of cancer patients. However, it has also created a lot of controversy among medical professionals. They are concerned about the possibility of misinterpreting test results and improper utilization of the information.

Generally, a sample of DNA is taken from the inside of a person's cheek. Afterward, it is analyzed by a computer algorithm. This algorithm determines the most likely ancestral origin. The results are then sent to the consumer by mail. Upon receiving the results, the consumer can then choose to check a box to receive further research. However, one of the major challenges that the Direct-To-Consumer Genetic Testing Devices industry faces is the absence of sufficient healthcare facilities. In some emerging economies, the lack of medical facilities is the main obstacle to the adoption of genetic testing.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more

Patient-Centered Medical Home; Is Used To Offer High-Standard, Inexpensive Primary Care

Image
Patient-Centered Medical Home The Patient-Centered Medical Home is a care model in which individuals are involved in a direct association with a chosen physician who organizes a supportive team of hospital experts, takes cooperative accountability for the comprehensive incorporated care offered to the patient, and sponsors and arranges suitable care with other professional physicians and community sources as per requirements. Use of PCMH develop disciplinary care teams to enhance care management and care administration of patient populaces focusing to increase safety, efficacy and standard in patient care. PCMH practices can enhance care and take benefits of private or public inducement payments that are offered to patients. The Patient Protection and Affordable Care Act (ACA) provides extra federal expenditure to regions for health homes helping Medicaid receivers. Supplier groups and hospitals can visit their federal and state officials and private insurers’ websites for data on exp
Read more